The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Diagnostics & Research
Medicalsystem Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.96% CNY10.39
America/New_York / 6 mai 2024 @ 02:30
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 989.24 mill |
| EPS: | 0.690 |
| P/E: | 15.06 |
| Earnings Date: | May 24, 2024 |
| SharesOutstanding: | 383.95 mill |
| Avg Daily Volume: | 4.67 mill |
| RATING 2024-05-06 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.42x |
| Company: PE 15.06 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.52x |
| Company: PE 15.06 | industry: PE 28.70 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY16.71 (60.82%) CNY6.32 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 10.13 - 10.77 ( +/- 3.08%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY10.39 (1.96% ) |
| Volume | 5.65 mill |
| Avg. Vol. | 4.67 mill |
| % of Avg. Vol | 121.09 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 300439.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
300439.SZ
Medicalsystem Biotechnology Co., Ltd. provides clinical diagnostics reagents and instruments in China. The company offers PCR kit, antibody test kit, antigen test kit, and nucleic acid reagent for COVID-19; automated biochemistry analyzers and bio reagents; hematology analyzers; urine analyzers; glycated hemoglobin analyzer; POCT; and chemiluminescene immunoassay analyzers. It also provides healthcare services. The company was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Medicalsystem Biotechnology Co., Ltd. in January 2017. Medicalsystem Biotechnology Co., Ltd. was founded in 2003 and is based in Ningbo, China.